bpc 157 and tb 500 10mg BPC-157 / TB-500 Blend (Dual Peptide) BPC-157 / TB-500 capsules -
Description
Trials conducted between 2001 and 2007 demonstrated statistically significant reductions in body fat, although the larger Phase IIb OPTIONS trial did not replicate these findings at sufficient magnitude for regulatory approval, and formal development was discontinued in 2007

Treatment with cyanocobalamin or hydroxocobalamin may unmask this condition

"Multifunctionality and Possible Medical Application of the BPC 157 Peptide: Literature and Patent Review." Pharmaceuticals , 2025

While individuals with mild vitamin B 12 deficiency may not experience symptoms, blood homocysteine and/or MMA may be elevated (18)

Research suggests these peptides may influence multiple overlapping biological pathways
